Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

Historical Holders from Q3 2014 to Q3 2025

Symbol
AUPH on Nasdaq
Type / Class
Equity / Common Shares, no par value
Shares outstanding
131M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
65.7M
Holdings value
$726M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
238
Number of buys
104
Number of sells
-109
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TANG CAPITAL MANAGEMENT LLC 7.3% $81.2M 10M TANG CAPITAL MANAGEMENT, LLC 28 Feb 2025
ILJIN SNT Co., Ltd. 5% $57.5M 6.54M Chin Kyu Huh 11 Aug 2025
ARMISTICE CAPITAL, LLC 4.47% $51.8M 6.4M Armistice Capital, LLC 31 Dec 2024

Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 65.7M $726M +$84.1M $11.05 238
2025 Q2 58.3M $494M -$31.8M $8.47 216
2025 Q1 62M $499M +$33.9M $8.04 210
2024 Q4 57.8M $519M +$4.1M $8.98 197
2024 Q3 57.6M $422M +$22M $7.33 180
2024 Q2 55.3M $316M +$4.96M $5.71 168
2024 Q1 54.7M $274M +$3.86M $5.01 173
2023 Q4 53.2M $478M +$38.7M $8.99 186
2023 Q3 50.3M $391M -$739K $7.77 194
2023 Q2 49.8M $483M -$1.74M $9.68 197
2023 Q1 50M $548M +$7.05M $10.96 182
2022 Q4 51.1M $221M -$24.2M $4.32 181
2022 Q3 55.4M $416M +$28.4M $7.52 177
2022 Q2 50.1M $504M +$74.4M $10.05 191
2022 Q1 42.2M $522M +$1.3M $12.38 176
2021 Q4 38.5M $881M -$106M $22.87 180
2021 Q3 43.1M $954M -$115K $22.13 160
2021 Q2 49M $635M -$42M $12.96 162
2021 Q1 52.1M $676M -$80.6M $12.99 163
2020 Q4 57.9M $801M -$115M $13.83 139
2020 Q3 64.8M $954M +$75M $14.73 144
2020 Q2 58.6M $953M -$24.8M $16.25 127
2020 Q1 60.3M $875M +$158M $14.51 122
2019 Q4 48.9M $990M +$509M $20.26 110
2019 Q3 25.5M $136M -$23.3M $5.34 68
2019 Q2 29.3M $193M -$3.06M $6.58 71
2019 Q1 29.8M $194M +$49.3M $6.50 76
2018 Q4 22.2M $151M +$3.05M $6.82 59
2018 Q3 21.5M $145M +$1.93M $6.64 62
2018 Q2 21.3M $122M -$2.41M $5.63 65
2018 Q1 21.7M $113M -$10M $5.19 63
2017 Q4 23.8M $108M -$516K $4.53 66
2017 Q3 23.4M $147M +$2.09M $6.27 59
2017 Q2 23.2M $142M -$8.84M $6.13 64
2017 Q1 23.8M $175M +$114M $7.34 71
2016 Q4 8.63M $18.1M +$8.66M $2.10 22
2016 Q3 4.24M $12.8M -$8.13M $3.01 14
2016 Q2 7.07M $20.1M +$878K $2.78 13
2016 Q1 6.74M $19.7M +$25K $2.92 16
2015 Q4 6.73M $16.8M -$1.11M $2.47 14
2015 Q3 7.11M $20.1M -$539K $2.84 11
2015 Q2 7.22M $21.7M -$1.34M $3.02 13
2015 Q1 7.61M $33.2M -$3.83M $4.37 11
2014 Q4 8.48M $30.7M +$8.98M $3.61 9
2014 Q3 6.02M $19.3M +$19.3M $3.20 8